Expression of FOXA1 and EZH2 in Breast Cancer and Association with Clinicopathological Features and TP53/RB1 Alterations

被引：0
|
作者：
Shi, Mingxia [1 ]
Yang, Shu [2 ]
Shi, Runhua [2 ]
Cheng, Siyuan [3 ]
Lopez, Liurka [3 ]
Yu, Xiuping [2 ]
机构：
[1] Univ S Alabama, Coll Med, Mobile, AL USA
[2] LSU Hlth Shreveport, Shreveport, LA USA
[3] LSU Hlth Sci Ctr Shreveport, Shreveport, LA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
263
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [21] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX
    McCarthy, Michael
    Jimenez, Rafael
    Hernandez, Loren Herrera
    Lohse, Christine
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Cheville, John
    Gupta, Sounak
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 634 - 634
  • [22] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX
    McCarthy, Michael
    Jimenez, Rafael
    Hernandez, Loren Herrera
    Lohse, Christine
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Cheville, John
    Gupta, Sounak
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 634 - 634
  • [23] The Correlation of TP53 and RB1 Genetic Alterations and Immunohistochemical (IHC) Expression in Invasive and Non-Invasive Urothelial Carcinoma
    Zheng, Xiaoyong
    Ren, Qinghu
    Sarungbam, Judy
    Jordan, Emmet J.
    Tickoo, Satish K.
    Fine, Samson
    Chen, Ying-Bei
    Berger, Michael F.
    Gopalan, Anuradha
    Sirintrapun, S. Joseph
    Iyer, Gopa
    Lee, Byron H.
    Cha, Eugene K.
    Berger, Michael F.
    Solit, David B.
    Reuter, Victor E.
    Al-Ahmadie, Hikmat
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 271A - 272A
  • [24] The Correlation of TP53 and RB1 Genetic Alterations and Immunohistochemical (IHC) Expression in Invasive and Non-Invasive Urothelial Carcinoma
    Zheng, Xiaoyong
    Ren, Oinghu
    Sarungbam, Judy
    Jordan, Emmet J.
    Tickoo, Satish K.
    Fine, Samson
    Chen, Ying-Bei
    Berger, Michael F.
    Gopalan, Anuradha
    Sirintrapun, S. Joseph
    Iyer, Gopa
    Lee, Byron H.
    Cha, Eugene K.
    Berger, Michael F.
    Solit, David B.
    Reuter, Victor E.
    Al-Ahmadie, Hikmat
    [J]. MODERN PATHOLOGY, 2016, 29 : 271A - 272A
  • [25] Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report
    Komori, Takahiro
    Kosaka, Takeo
    Tanaka, Tomoki
    Watanabe, Keitaro
    Yasumizu, Yota
    Mikami, Shuji
    Oya, Mototsugu
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2023, 11 (04): : 339 - 343
  • [26] Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis
    Ito, Takaaki
    Matsuo, Akira
    Hassan, Wael Abdo
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 213 - 219
  • [27] PHENOTYPIC-GENOTYPIC CORRELATION OF TP53 AND RB1 IN UROTHELIAL CARCINOMA
    Audenet, Francois
    Isharwal, Sumit
    Zheng, Xiaoyong
    Jordan, Emmet
    Iyer, Gopa
    Lee, Byron
    Cha, Eugene
    Donahue, Timothy
    Donat, Machele
    Herr, Harry
    Dalbagni, Guido
    Bochner, Bernard
    Berger, Michael
    Solit, David
    Al-Ahmadie, Hikmat
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E644 - E644
  • [28] Concurrent somatic alterations of TP53 and RB1 in Chinese lung adenocarcinoma with or without EGFR mutations.
    Wang, Jun
    Chen, Gang
    Zhang, Bicheng
    Sun, Jianguo
    Liang, Jing
    Liu, Xiaolin
    Li, Yan
    Wang, Baocheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers
    Ammous-Boukhris, Nihel
    Ayadi, Wajdi
    Derbel, Mariem
    Allaya-Jaafar, Nesrine
    Charfi, Slim
    Daoud, Jamel
    Sellami-Boudawara, Tahya
    Mokdad-Gargouri, Raja
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [30] Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.
    Hammer, Liat
    Rebernick, Ryan
    McFarlane, Matthew
    Westbrook, Thomas
    Hazime, Munna
    Hammoud, Tanya
    Chiu, Pin-en
    Xavier, Owens
    Wu, Yi-Mi
    Robinson, Dan R.
    Spratt, Daniel Eidelberg
    Alva, Ajjai Shivaram
    Jackson, William C.
    Reichert, Zachery R.
    Alumkal, Joshi J.
    Chinnaiyan, Arul
    Cieslik, Marcin
    Dess, Robert Timothy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345